Omenn syndrome in the context of other B cell-negative severe combined immunodeficiencies

Research output: Contribution to journalArticle

Abstract

Severe combined immunodeficiencies represent a heterogeneous group of hereditary defects of the immune system that affect both T and B cells and whose etiology has only recently begun to be understood. A portion of these SCID patients bear a defect in either of the two recombination-activating genes, Rag-1 or Rag-2, while others have mutations in a newly identified gene, Artemis. Omenn syndrome is an unusual severe immunodeficiency with T cells but no B cells, and peculiar features also due to a defect in Rag-1 or Rag-2 genes. All these three forms are characterized by an impairment of the VDJ recombination, the process that insures the somatic diversification of immunoglobulin and T cell receptor-encoding genes. Recent findings have enabled us to better understand the pathophysiology of these three immunodeficiencies, which affect the V(D)J recombination process to a different extent and in different ways.

Original languageEnglish
Pages (from-to)218-221
Number of pages4
JournalIsrael Medical Association Journal
Volume4
Issue number3
Publication statusPublished - 2002

Keywords

  • Artemis
  • Omenn syndrome
  • Recombination-activating genes
  • Severe combined immunodeficiencies

ASJC Scopus subject areas

  • Medicine(all)
  • Bioengineering

Fingerprint Dive into the research topics of 'Omenn syndrome in the context of other B cell-negative severe combined immunodeficiencies'. Together they form a unique fingerprint.

  • Cite this